Patents by Inventor Raj Devarajan

Raj Devarajan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
    Publication number: 20250017851
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Application
    Filed: September 17, 2024
    Publication date: January 16, 2025
    Applicant: Cristcot LLC
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone acetate suppository formulation for treatment of disease
    Patent number: 12115251
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Grant
    Filed: February 27, 2024
    Date of Patent: October 15, 2024
    Assignee: Cristcot LLC
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone acetate suppository formulation for treatment of disease
    Patent number: 12115253
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Grant
    Filed: February 27, 2024
    Date of Patent: October 15, 2024
    Assignee: Cristcot LLC
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone acetate suppository formulation for treatment of disease
    Patent number: 12115252
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Grant
    Filed: February 27, 2024
    Date of Patent: October 15, 2024
    Assignee: Cristcot LLC
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone acetate suppository formulation for treatment of disease
    Patent number: 12109306
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Grant
    Filed: February 27, 2024
    Date of Patent: October 8, 2024
    Assignee: Cristcot LLC
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone acetate suppository formulation for treatment of disease
    Patent number: 12090226
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Grant
    Filed: February 27, 2024
    Date of Patent: September 17, 2024
    Assignee: Cristcot LLC
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
    Publication number: 20240207181
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Application
    Filed: February 27, 2024
    Publication date: June 27, 2024
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
    Publication number: 20240207180
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Application
    Filed: February 27, 2024
    Publication date: June 27, 2024
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
    Publication number: 20240207182
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Application
    Filed: February 27, 2024
    Publication date: June 27, 2024
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
    Publication number: 20240197629
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Application
    Filed: February 27, 2024
    Publication date: June 20, 2024
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
    Publication number: 20240197630
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Application
    Filed: February 27, 2024
    Publication date: June 20, 2024
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone acetate suppository formulation for treatment of disease
    Patent number: 11376217
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: July 5, 2022
    Assignee: Cristcot LLC
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
    Publication number: 20200315963
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Application
    Filed: April 23, 2020
    Publication date: October 8, 2020
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone acetate suppository formulation for treatment of disease
    Patent number: 10653623
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: May 19, 2020
    Assignee: Cristcot LLC
    Inventors: Jennifer J. Davagian, Raj Devarajan
  • Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
    Publication number: 20180036235
    Abstract: The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
    Type: Application
    Filed: March 10, 2016
    Publication date: February 8, 2018
    Inventors: Jennifer J. Davagian, Raj Devarajan